Lilly launches Tanstrive (Selpercatinib), a RET inhibitor to treat advanced cancers with RET gene alteration Read more
Servier India launches biomarker testing initiative for AML and Cholangiocarcinoma patients Read more
Queens University Belfast study reveals strong economic case for precision oncology medicine Read more